AU2002333386A1 - Use of c-src inhibitors alone or in combination with sti571 for the treatment of leukaemia - Google Patents

Use of c-src inhibitors alone or in combination with sti571 for the treatment of leukaemia

Info

Publication number
AU2002333386A1
AU2002333386A1 AU2002333386A AU2002333386A AU2002333386A1 AU 2002333386 A1 AU2002333386 A1 AU 2002333386A1 AU 2002333386 A AU2002333386 A AU 2002333386A AU 2002333386 A AU2002333386 A AU 2002333386A AU 2002333386 A1 AU2002333386 A1 AU 2002333386A1
Authority
AU
Australia
Prior art keywords
sti571
leukaemia
treatment
combination
src inhibitors
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
AU2002333386A
Inventor
Nicholas J. Donato
Doriano Fabbro
Michael Hallek
Paul William Manley
Jurgen Mestan
Moshe Talpaz
Markus Warmuth
Ji Wu
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Novartis AG
Original Assignee
Novartis AG
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Novartis AG filed Critical Novartis AG
Publication of AU2002333386A1 publication Critical patent/AU2002333386A1/en
Abandoned legal-status Critical Current

Links

AU2002333386A 2001-08-10 2002-08-09 Use of c-src inhibitors alone or in combination with sti571 for the treatment of leukaemia Abandoned AU2002333386A1 (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US60/311,690 2001-08-10

Publications (1)

Publication Number Publication Date
AU2002333386A1 true AU2002333386A1 (en) 2003-02-24

Family

ID=

Similar Documents

Publication Publication Date Title
AU2002339157A1 (en) Inhibitors of the notch signalling pathway for use in the treatment of cancer
AU2001259758A1 (en) Interleukin-1 inhibitors in the treatment of diseases
AU2003206785A1 (en) Use of tyrosine kinase inhibitors for the treatment of inflammatory processes
EP1628530B8 (en) Methods and compositions for the prevention and treatment of sepsis
PL370029A1 (en) 2-amino-4-heteroarylaminopyrimidine derivatives for use in the treatment of cancer
SG104356A1 (en) Absorbent body and absorbent article having the absorbent body
HK1061212A1 (en) Pyranoindazoles and their use for the treatment ofglaucoma
ZA200208228B (en) Use of il-18 inhibitors for the treatment and/or prevention of athesclerosis
AU2002248269A1 (en) Use of p38 inhibitors for the treatment of inflammation-enhanced cough
AU2003255993A1 (en) Diazabicyclic compounds useful in the treatment of cns and other disorders
AU2002247208A1 (en) Selective pde3b inhibitors and use of the same in therapy
AU2003205926A1 (en) Use of pde5 inhibitors such as sildenafil in the treatment of polycystic ovary syndrome
IL159879A0 (en) Use of bibn4096 in combination with other antimigraine drugs for the treatment of migraine
PL361733A1 (en) Sulfamidothienopyrimidines and the use of the same as phosphodiesterase v inhibitors
AU2001253165A1 (en) Use of fluorocarbons for the prevention of surgical adhesions
AU2002338734A1 (en) Use of phosphorodiesterase IV inhibitors
AU2003220026A1 (en) Methods and compositions for the treatment of ischemia
AU2003297363A1 (en) Use of cathepsin k inhibitors for the treatment of glaucoma
AU2003205452A1 (en) Bmp inhibitors for the treatment of spondyloarthropathies
AU2001239301A1 (en) Use of ectoin or ectoin derivatives for the prophylaxis and/or treatment of uv-induced immunosuppression
AU2002333386A1 (en) Use of c-src inhibitors alone or in combination with sti571 for the treatment of leukaemia
AU2002241162A1 (en) Intimins in the prevention or treatment of infections:ii
AU2002342715A1 (en) Novel methods for the treatment and prevention of pain using stress-activated protein kinase inhibitors
AU2003291977A1 (en) Compounds useful in the diagnosis and treatment of pregnancy-associated malaria
AU2003251751A1 (en) Agents capable of inhibiting ras and uses thereof